Maven Securities LTD Intellia Therapeutics, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $813,546 - $1.09 Million	-6,146 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $1.23 Million - $3.26 Million	-20,142 Reduced 76.62%	6,146 $1.22 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $1.55 Million - $2.78 Million	-33,280 Reduced 55.87%	26,288 $2.09 Million
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $1.12 Million - $3.78 Million	59,568 New	59,568 $3.37 Million

314

89.3M

686K

599K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.73B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.